Hanmi Pharm. Co.  Ltd

Hanmi Pharm. Co. Ltd


Company description

Hanmi has shown remarkable growth since its foundation in 1973 and has now become the most spotlighted company among Korean pharmaceutical companies. We are proud to be known as a global leader in the quality API production of cephalosporins, cardiovascular, anti-diabetics, gastrointestinal, and CNSs. The facilities have been inspected and approved by UK MHRA, German BSG, Australian TGA, and US FDA. Hanmi has been successfully developed and marketed New Combination drug and a series of IMDs with its own patented process, and also succeeded in developing LAPSCOVERY technology, which is enhancing the half-life time for bio-products.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 12F20 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 111G31 See our Exhibitor Profile   See full Exhibitor List
16 may 2017

CPhI North America 2017

16-18 May, 2017 Philadelphia, USA We were at stand 1003 See our Exhibitor Profile   See full Exhibitor List
Hanmi Pharm. Co. Ltd

Contact information




View all contact information